Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.96K Hold
46
﹤0.01% 599
2026
Q1
$10.3K Hold
46
﹤0.01% 545
2025
Q4
$11.1K Hold
46
﹤0.01% 540
2025
Q3
$12.6K Hold
46
0.01% 469
2025
Q2
$11.9K Hold
46
0.01% 456
2025
Q1
$10.3K Hold
46
0.01% 463
2024
Q4
$10.5K Hold
46
0.01% 432
2024
Q3
$11.2K Hold
46
0.01% 432
2024
Q2
$8.81K Hold
46
0.01% 460
2024
Q1
$9.11K Hold
46
0.01% 452
2023
Q4
$7.91K Buy
+46
New +$7.07K 0.01% 464

Other funds holding RMD

WealthCollab's RMD Position: Q2 2026 in Review

WealthCollab held its ResMed (RMD) position steady in Q2 2026 at 46 shares worth $8.96K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

WealthCollab first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $12.6K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • WealthCollab held 46 shares of ResMed worth $8.96K as of Q2 2026.
  • WealthCollab left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #599 holding.
  • WealthCollab first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's ResMed position peaked at $12.6K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.